PROVECTUS BIOPHARMACEUTICALS, INC.
PVCT · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Pershing Edward: Form 4
Insider disclosure · Filed · Report period 06 Nov 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000315545 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PVCT on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 800 S. Gay Street, Suite 1610, Knoxville, TN, 37929
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- PROVECTUS PHARMACEUTICALS INC (to 18 Dec 2013), PROVECTUS PHARMACEUTICAL INC (to 15 May 2002), ZAMAGE DIGITAL IMAGING INC (to 01 Apr 2002), SPM GROUP INC (to 14 Nov 2001)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields